serine/threonine Kinase 17b (STK17B) (Internal Region) Peptide
-
- Target See all DRAK2 (STK17B) products
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- Peptide Type
- Synthetic
- Protein Region
- Internal Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- DRAK2 peptide is a synthetic peptide cooresponding to 12 amino acids from the internal region of DRAK2.
-
-
- Application Notes
- DRAK2 Peptide is used for blocking the activity of DRAK2 antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- DRAK2 peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 ?L water, the concentration will be 0.5 mg/mL.
- Handling Advice
- When reconstituted minimize freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C.
-
- Target
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- Synonyms
- zgc:65989 Peptide, STK17B Peptide, DRAK2 Peptide, Drak2 Peptide, 3110009A03Rik Peptide, AI120141 Peptide, serine/threonine kinase 17b (apoptosis-inducing) Peptide, serine/threonine kinase 17b Peptide, stk17b Peptide, STK17B Peptide, Stk17b Peptide
- Gene ID
- 9262
- NCBI Accession
- NP_005682, NP_064693
- UniProt
- O94768
-